TY - JOUR
T1 - Transcultural differences in suicide attempters
T2 - Analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder
AU - Altamura, A. C.
AU - Mundo, E.
AU - Bassetti, R.
AU - Green, A.
AU - Lindenmayer, J. P.
AU - Alphs, L.
AU - Meltzer, H. Y.
N1 - Funding Information:
This study was supported by the Novartis Pharmaceuticals Corporation.
PY - 2007/1
Y1 - 2007/1
N2 - The aim of the study was to investigate transcultural differences between schizophrenia spectrum disorder patients who did or did not attempt suicide. DSM-IV schizophrenia (N = 609) or schizoaffective disorder (N = 371) patients who participated in the multicentre International Suicide Prevention Trial (InterSePT) were studied. Patients were sub-divided into 5 groups according to the different geographical regions of recruitment: North America (NA), Europe (EUR), East Europe (EEUR), South Africa (SAf), and South America (SA). The main lifetime clinical variables were compared, within each group, between attempters and non-attempters. The presence of comorbid substance abuse disorder and smoking was associated with suicide attempts in all the geographical groups considered (NA: χ12 = 7.575, p < 0.01 and χ12 = 69.549, p < 0.0001; EUR: χ12 = 55.068, p < 0.0001, and χ12 = 48.431, p < 0.0001; EEUR: χ12 = 164.628, p < 0.000, and χ12 = 5.127, p < 0.01; SA: χ12 = 30.204, p < 0.0001 and χ12 = 11.710, p = 0.001) except for SAf. For the other clinical variables various differences were found across the different groups. Variables related to suicide behavior were similar across the five groups investigated, with differences only in the age at the first suicide attempt (earlier in the NA sample) and the number of lifetime suicide attempts (higher in the NA sample). Results from this study show that, while some suicide-related clinical characteristics in schizophrenia patients are consistent worldwide suggesting the influence of stable biological traits, other variables may vary across different geographical areas suggesting environmental influences.
AB - The aim of the study was to investigate transcultural differences between schizophrenia spectrum disorder patients who did or did not attempt suicide. DSM-IV schizophrenia (N = 609) or schizoaffective disorder (N = 371) patients who participated in the multicentre International Suicide Prevention Trial (InterSePT) were studied. Patients were sub-divided into 5 groups according to the different geographical regions of recruitment: North America (NA), Europe (EUR), East Europe (EEUR), South Africa (SAf), and South America (SA). The main lifetime clinical variables were compared, within each group, between attempters and non-attempters. The presence of comorbid substance abuse disorder and smoking was associated with suicide attempts in all the geographical groups considered (NA: χ12 = 7.575, p < 0.01 and χ12 = 69.549, p < 0.0001; EUR: χ12 = 55.068, p < 0.0001, and χ12 = 48.431, p < 0.0001; EEUR: χ12 = 164.628, p < 0.000, and χ12 = 5.127, p < 0.01; SA: χ12 = 30.204, p < 0.0001 and χ12 = 11.710, p = 0.001) except for SAf. For the other clinical variables various differences were found across the different groups. Variables related to suicide behavior were similar across the five groups investigated, with differences only in the age at the first suicide attempt (earlier in the NA sample) and the number of lifetime suicide attempts (higher in the NA sample). Results from this study show that, while some suicide-related clinical characteristics in schizophrenia patients are consistent worldwide suggesting the influence of stable biological traits, other variables may vary across different geographical areas suggesting environmental influences.
KW - Clinical variables
KW - Schizophrenia
KW - Suicide
KW - Transcultural
UR - http://www.scopus.com/inward/record.url?scp=33845309633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845309633&partnerID=8YFLogxK
U2 - 10.1016/j.schres.2006.08.023
DO - 10.1016/j.schres.2006.08.023
M3 - Article
C2 - 17097854
AN - SCOPUS:33845309633
SN - 0920-9964
VL - 89
SP - 140
EP - 146
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 1-3
ER -